|
|
 |
Jiangsu Aidea Pharmaceutical Co.,Ltd.
|
|
|
| |
|
|
Jiangsu Aidea Pharmaceutical Co., Ltd. (Aidea Pharma, 688488.SH) was established in 2009 and listed on the Shanghai Stock Exchange STAR Market in 2020. As a high-tech pharmaceutical company, Aidea Pharma focuses on the development of anti-HIV/AIDS product portfolio while leveraging its competitive advantages in the field of human urinary proteins production.
A pioneer in R&D of anti-HIV/AIDS products in China, with two innovative drugs successfully approved for marketing
A leading manufacturer of human urinary protein products in China, with five products recognized as provincial high-tech products
A company dedicated to exploring innovative medicines, serving unmet clinical needs worldwide with its unique expertise and professional talents
|
Registration Date |
2018/01/05 (Year/Month/Date) |
Buyer / Seller in EC21 |
Seller |
Business Type |
Manufacturer |
Year established |
2009 |
Employees total |
101 - 500 |
Annual revenue |
USD 50,000,001 - 100,000,000 |
|
Contact Information |
 |
|
Company |
Jiangsu Aidea Pharmaceutical Co.,Ltd. |
Address |
No. 69, Xin Ganquan West Road, Hanjiang District,Yangzhou Yangzhong Jiangsu 225008 China |
Phone |
86 - 20 - 66393971 |
Homepage |
http://www.aidea.com.cn |
Contact |
Swing Xue
|
|
|
|
| |
|
|
|